首页> 美国卫生研究院文献>Journal of Biomolecular Techniques : JBT >Protein Sequencing Research Group (PSRG): Results of the PSRG 2013 Study Year 2: Terminal Sequencing of Standard Proteins in a Mixture
【2h】

Protein Sequencing Research Group (PSRG): Results of the PSRG 2013 Study Year 2: Terminal Sequencing of Standard Proteins in a Mixture

机译:蛋白质测序研究组(PSRG):PSRG 2013研究年2的结果:混合物中标准蛋白质的末端测序

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Establishing the N- and C-terminal sequences of intact proteins plays a critical role in biochemistry and drug development. Terminal sequence analysis is necessary for quality control of protein biologics, for determining sites of signal peptide cleavage events, for characterizing monoclonal antibodies, and in elucidating sequences of genes from uncommon species. N-terminal sequencing is in the midst of a technology transition from classical Edman sequencing to mass spectrometry (MS) based terminal sequencing, with C-terminal sequencing largely accessible only through top-down MS. Protein homogeneity (absence of interfering protein, non-protein contaminants and buffer components) is critical to the success of analysis. While it has been straightforward to isolate the protein of interest out of protein mixtures in preparation for Edman sequencing, core facilities now need to adopt novel sample preparation techniques to isolate proteins in high purity and make them amenable for terminal sequencing by MS. There is a lack of easy-to-use, field proven methods for sample clean-up.In order to address the upcoming change in technology platforms, the PSRG is conducting a two-year study with the goal of sample preparation and terminal sequencing of a protein mixture. The 2013 study is the second phase towards this goal and entails terminal sequencing and identification of fusion proteins, which were provided in mixture. Participants used Edman and/or MS techniques, along with bioinformatics tools, to derive the termini of the sample proteins. Study participants were directed to a website to anonymously upload sequences and supporting data.Our analysis focused on comparison of results obtained by different technology platforms. The results obtained by Edman sequencing and MS as well as information on instrumentation and protocols will be presented. This data and information will be provided to the community in conjunction with year one of the study, which entailed the same proteins supplied as isolated, homogeneous proteins.
机译:建立完整蛋白质的N和C末端序列在生物化学和药物开发中起着至关重要的作用。末端序列分析对于蛋白质生物制剂的质量控制,确定信号肽裂解事件的位点,表征单克隆抗体以及阐明罕见物种的基因序列是必需的。 N端测序正处于从经典的Edman测序到基于质谱(MS)的终端测序的技术过渡之中,C端测序在很大程度上只能通过自上而下的MS进行访问。蛋白质同质性(无干扰蛋白质,非蛋白质污染物和缓冲液成分)对于分析的成功至关重要。尽管从蛋白质混合物中分离出目标蛋白质以进行Edman测序很简单,但核心设施现在需要采用新颖的样品制备技术来分离高纯度的蛋白质,并使其适合于通过MS进行末端测序。缺乏易于使用,经过现场验证的样品净化方法。为了应对技术平台即将发生的变化,PSRG正在进行为期两年的研究,目标是样品制备和最终测序蛋白质混合物。 2013年的研究是朝着这个目标迈进的第二阶段,需要对终端蛋白进行最终测序和鉴定,而融合蛋白必须以混合物形式提供。参与者使用Edman和/或MS技术以及生物信息学工具来获得样品蛋白质的末端。研究参与者被定向到一个匿名上传序列和支持数据的网站。我们的分析重点是比较不同技术平台获得的结果。将介绍通过Edman测序和MS获得的结果,以及有关仪器和规程的信息。这些数据和信息将与研究的第一年一起提供给社区,该研究需要将相同的蛋白质作为分离的同质蛋白质提供。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号